SIK1 and metabolic dysfunction-associated steatotic liver disease: Additionally, metformin, a widely used hypoglycemic drug, which attenuated hyperglycaemia and NAFLD in HFD/STZ-induced diabetic rats [29], increased SIK1 expression levels in HepG2 cells cultured in high glucose conditions [19].